Funk, D J <br/><br/>
The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Dec 2011 
 - 592-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>1399-3062 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-3062.2011.00636.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Infective Agents--adverse effects<br/>Anti-Inflammatory Agents--therapeutic use<br/>Anticoagulants--therapeutic use<br/>Hemorrhage--chemically induced<br/>Humans<br/>Immunosuppression Therapy--adverse effects<br/>Middle Aged<br/>Organ Transplantation<br/>Postoperative Complications--prevention & control<br/>Protein C--adverse effects<br/>Recombinant Proteins--adverse effects<br/>Retrospective Studies<br/>Shock, Septic--drug therapy<br/>Treatment Outcome